ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,436Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 617

$1.17M Total Retail Price of All Prescriptions

Rank: 2 out of 617

991 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 991 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

8% of this provider’s 991 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 23,179 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 1,103 967 1 1
OMEPRAZOLE 951 764 2 3
SIMVASTATIN 833 761 3 2
TRAMADOL HCL 581 546 4 15
LISINOPRIL 557 547 5 5
POTASSIUM CHLORIDE 542 496 6 10
HYDROCHLOROTHIAZIDE 539 513 7 13
FUROSEMIDE 534 503 8 4
METOPROLOL TARTRATE 508 460 9 11
AMLODIPINE BESYLATE 502 479 10 6
WARFARIN SODIUM 486 472 11 7
ENALAPRIL MALEATE 443 413 12 34
METFORMIN HCL 442 377 13 9
LOSARTAN POTASSIUM 440 429 14 22
GABAPENTIN 440 367 14 16
CARVEDILOL 434 415 16 19
PRAVASTATIN SODIUM 415 391 17 21
HYDROCODONE-ACETAMINOPHEN 395 388 S3 18 8
CITALOPRAM HBR 369 348 19 18
POLYETHYLENE GLYCOL 3350 360 298 20 32
FAMOTIDINE 325 285 21 54
ATENOLOL 292 270 22 17
ALLOPURINOL 283 270 23 27
ATORVASTATIN CALCIUM 276 244 24 14
ZOLPIDEM TARTRATE 267 259 25 23
METOPROLOL SUCCINATE 264 226 26 12
MELOXICAM 254 212 27 24
PANTOPRAZOLE SODIUM 235 175 28 37
BISOPROLOL FUMARATE 231 217 29 100
NAMENDA 226 213 30 35
SPIRONOLACTONE 217 212 31 42
SERTRALINE HCL 217 162 31 20
TAMSULOSIN HCL 212 184 33 26
DONEPEZIL HCL 211 193 34 30
ISOSORBIDE MONONITRATE ER 203 194 35 52
PREDNISONE 195 157 36 31
AMITRIPTYLINE HCL 189 166 R 37 56
FLUTICASONE PROPIONATE 187 143 38 36
LOSARTAN-HYDROCHLOROTHIAZIDE 177 150 39 46
LOVASTATIN 170 153 40 57
CARBIDOPA-LEVODOPA 168 168 41 69
GLIMEPIRIDE 163 135 42 33
ALENDRONATE SODIUM 163 132 42 25
FENTANYL 154 153 S2 44 45
MIRTAZAPINE 151 116 45 50
TORSEMIDE 151 148 45 110
PAROXETINE HCL 143 122 47 62
LANTUS 138 116 48 39
TRIAMTERENE-HCTZ 135 107 49 47
QUETIAPINE FUMARATE 132 110 50 78
BUSPIRONE HCL 124 107 51 131
LISINOPRIL-HYDROCHLOROTHIAZIDE 117 112 52 29
SPIRIVA 115 105 53 61
DOXYCYCLINE HYCLATE 114 94 54 113
ACTOS 114 110 54 85
SPIRONOLACTONE-HCTZ 112 110 56 189
SYMBICORT 111 98 57 141
CLOPIDOGREL 110 91 58 53
ROPINIROLE HCL 109 109 59 66
DOXAZOSIN MESYLATE 108 107 60 79
CIPROFLOXACIN HCL 101 92 61 60
RISPERIDONE 101 87 61 71
CLONIDINE HCL 99 98 63 55
SINGULAIR 96 59 64 106
SULFAMETHOXAZOLE-TRIMETHOPRIM 95 75 65 91
EVISTA 95 85 65 119
CRESTOR 94 53 67 28
ADVAIR DISKUS 94 61 67 38
TRIAMCINOLONE ACETONIDE 93 80 69 102
PLAVIX 91 72 70 86
VERAPAMIL ER 90 50 71 90
AMOXICILLIN 86 76 72 135
PRAMIPEXOLE DIHYDROCHLORIDE 83 76 73 153
DILTIAZEM 24HR CD 78 75 74 117
LEVOFLOXACIN 78 65 74 89
RANITIDINE HCL 77 50 76 40
DETROL LA 76 64 77 127
NOVOLOG 75 62 78 137
TRAZODONE HCL 75 65 78 51
METFORMIN HCL ER 75 64 78 72
GEMFIBROZIL 74 55 81 105
CYMBALTA 71 61 82 49
LEVEMIR FLEXPEN 69 60 83 212
ALBUTEROL SULFATE 68 68 84 112
HUMALOG 68 62 84 152
BUPROPION XL 67 36 86 161
LYRICA 67 49 86 92
DIOVAN 66 64 88 41
PEN NEEDLE 66 59 88 174
DICLOFENAC SODIUM 65 36 90 98
LIDODERM 63 63 91 188
BUMETANIDE 62 58 92 124
FENOFIBRATE 61 51 93 58
DIVALPROEX SODIUM 61 15 93 111
PROPRANOLOL HCL 61 60 93 109
MONTELUKAST SODIUM 61 38 93 192
ABILIFY 60 24 97 131
FLUOXETINE HCL 59 51 98 73
NITROGLYCERIN PATCH 59 59 98 198
HYDRALAZINE HCL 58 58 100 164
INSULIN SYRINGE 58 47 100 148
TERAZOSIN HCL 58 53 100 96
CEFPROZIL 57 49 103 297
BACLOFEN 57 38 103 146
HUMULIN 70-30 57 56 103 297
DIVALPROEX SODIUM ER 56 44 106 181
OXYBUTYNIN CHLORIDE 55 55 107 88
NYSTATIN 55 47 107 228
AMIODARONE HCL 53 44 109 129
AZITHROMYCIN 53 44 109 70
CELEBREX 51 43 111 63
NOVOLOG FLEXPEN 51 35 111 203
CYCLOBENZAPRINE HCL 51 34 R 111 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 24, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.